High risk of obesity and weight gain for HIV-infected uninsured minorities

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 2, 2014, Pages

  Taylor, Barbara S ^a,b   Liang, Yuanyuan ^a,b   Garduño, L Sergio ^a   Walter, Elizabeth A ^a,c   Gerardi, Margit B ^a   Anstead, Gregory M ^a   Bullock, Delia ^a   Turner, Barbara J ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b The University of Texas Health Science Center at Houston   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Health disparities; HIV; Obesity; Observational cohort; Weight gain

Indexed keywords

ADULT; BODY MASS INDEX; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; MINORITY GROUPS; OBESITY; RISK ASSESSMENT; WEIGHT GAIN;

EID: 84893724911     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000010     Document Type: Article

References (68)

1. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity in the United States, 2009-2010. In: National Center for Health Statistics Data Brief No. 82, ed. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
2. Wang Y, Beydoun MA. The obesity epidemic in the United States- gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007; 29:6-28.
3. Centers for Disease Control and Prevention (CDC). Vital signs: statespecific obesity prevalence among adults - United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:951-955.
4. Robert SA, Reither EN. A multilevel analysis of race, community disadvantage, and body mass index among adults in the US. Soc Sci Med. 2004;59:2421-2434.
5. Zhang Q, Wang Y. Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000. Obes Res. 2004;12:1622-1632.
6. Zhang Q, Wang Y. Socioeconomic inequality of obesity in the United States: do gender, age, and ethnicity matter? Soc Sci Med. 2004;58: 1171-1180.
7. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
8. Centers for Disease Control and Prevention. Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence - 24 cities, United States, 2006-2007. MMWR Morb Mortal Wkly Rep. 2011;60:1045-1049.
9. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6:e17502.
10. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36(suppl 2):S69-S78.
11. Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191-201.
12. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis. 2004;39: 1223-1230.
13. Achhra AC, Amin J, Law MG, et al. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS. 2010;24:1877-1886.
14. Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis. 2012;205(suppl 3):S355-S361.
15. Triant VA, Lee H, Hadigan C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92: 2506-2512.
16. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406.
17. Islam FM, Wu J, Jansson J, et al. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13:453-468.
18. Smit E, Skolasky RL, Dobs AS, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol. 2002;156:211-218.
19. Mocroft A, Sabin CA, Youle M, et al. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. J Acquir Immune Defic Syndr. 1999;21: 401-407.
20. Hogg R, Samji H, Cescon A, et al. Temporal changes in life expectancy of HIV+ individuals: North America. Paper presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, WA.
21. Rodger A, Lodwick R, Schechter M, et al. Mortality in patients with wellcontrolled HIV and high CD4 counts in the cART arms of the SMART and ESPRIT Randomized Clinical Trials compared to the general population. Paper presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, WA.
22. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007; 167:1720-1728.
23. Schafer I, von Leitner EC, Schon G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5:e15941.
24. Kim DJ, Westfall AO, Chamot E, et al. Multimorbidity patterns in HIVinfected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr. 2012;61:600-605.
25. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39:557-561.
26. Crum-Cianflone N, Tejidor R, Medina S, et al. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS. 2008;22:925-930.
27. Mariz CA, Albuquerque Mde F, Ximenes RA, et al. Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity. Cad Saude Publica. 2011;27:1997-2008.
28. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003;37(suppl 2): S69-S80.
29. Tate T, Willig AL, Willig JH, et al. HIV infection and obesity: where did all the wasting go? Antivir Ther. 2012;17:1281-1289.
30. Hodgson LM, Ghattas H, Pritchitt H, et al. Wasting and obesity in HIV outpatients. AIDS. 2001;15:2341-2342.
31. Buchacz K, Baker RK, Palella F, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18:65-75.
32. Lakey W, Yang LY, Yancy W, et al. From wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses. 2013;29:435-440.
33. Koethe JR, Jenkins CA, Shepherd BE, et al. An optimal body mass index range associated with improved immune reconstitution among HIVinfected adults initiating antiretroviral therapy. Clin Infect Dis. 2011; 53:952-960.
34. Crum-Cianflone N, Roediger MP, Eberly L, et al. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One. 2010;5:e10106.
35. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccin Immunol. 2011;18:940-946.
36. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2007-2010.
37. Centers for Disease Control and Prevention (CDC). Differences in prevalence of obesity among black, white, and hispanic adults - United States, 2006-2008. MMWR Morb Mortal Wkly Rep. 2009;58:740-744.
38. DeNavas-Walt C, Proctor BD, Smith JC. Income, poverty, and health insurance coverage in the United States: 2010. In: U.S. Census Bureau, Current Population Reports, P60-239. Washington, DC: U.S. Government Printing Office; 2011.
39. Monheit AC, Vistnes JP. Race/ethnicity and health insurance status: 1987 and 1996. Med Care Res Rev. 2000;57(suppl 1):11-35.
40. Haas JS, Adler NE. The Causes of Vulnerability: Disentangling the Effects of Race, Socioeconomic Status and Insurance Coverage on Health. Washington, DC: The Institute of Medicine; 2001.
41. Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235-252.
42. Haas JS, Lee LB, Kaplan CP, et al. The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health. 2003;93:2105-2110.
43. Yanovski JA, Yanovski SZ, Sovik KN, et al. A prospective study of holiday weight gain. N Engl J Med. 2000;342:861-867.
44. Williamson DF, Kahn HS, Remington PL, et al. The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med. 1990; 150:665-672.
45. U.S. Census Bureau; Census 2000, Summary File 3, Table DP-3; generated by L. Sergio Garduno; using American FactFinder. Available at: http://factfinder2.census.gov. Accessed April 10, 2012.
46. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000.
47. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS. 1998; 12:1645-1651.
48. Stein JH, Hsue PY. Inflammation, immune activation, and CVD risk in individuals with HIV infection. JAMA. 2012;308:405-406.
49. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIVinfected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625-1631.
50. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126.
51. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIVinfected individuals. J Acquir Immune Defic Syndr. 2003;33:506-512.
52. Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71-82.
53. Golubic R, Ekelund U, Wijndaele K, et al. Rate of weight gain predicts change in physical activity levels: a longitudinal analysis of the EPICNorfolk cohort. Int J Obes (Lond). 2013;37:404-409.
54. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
55. Clarke P, O'Malley PM, Johnston LD, et al. Social disparities in BMI trajectories across adulthood by gender, race/ethnicity and lifetime socioeconomic position: 1986-2004. Int J Epidemiol. 2009;38:499-509.
56. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000;23:81-88.
57. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr. 1993;6:1130-1138.
58. Palenicek JP, Graham NM, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10: 366-373.
59. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80-85.
60. Womack J, Tien PC, Feldman J, et al. Obesity and immune cell counts in women. Metabolism. 2007;56:998-1004.
61. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Obesity among HIVinfected persons: impact of weight on CD4 cell count. AIDS. 2010;24: 1069-1072.
62. ter Bogt NC, Bemelmans WJ, Beltman FW, et al. Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial. Arch Intern Med. 2011;171:306-313.
63. ter Bogt NC, Bemelmans WJ, Beltman FW, et al. Preventing weight gain: one-year results of a randomized lifestyle intervention. Am J Prev Med. 2009;37:270-277.
64. Tsai AG, Wadden TA, Rogers MA, et al. A primary care intervention for weight loss: results of a randomized controlled pilot study. Obesity (Silver Spring). 2010;18:1614-1618.
65. Jay M, Gillespie C, Schlair S, et al. The impact of primary care resident physician training on patient weight loss at 12 months. Obesity (Silver Spring). 2013;21:45-50.
66. Engelson ES, Agin D, Kenya S, et al. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism. 2006;55:1327-1336.
67. Barroso CS, Peters RJ, Johnson RJ, et al. Beliefs and perceived norms concerning body image among African-American and Latino teenagers. J Health Psychol. 2010;15:858-870.
68. Paeratakul S, White MA, Williamson DA, et al. Sex, race/ethnicity, socioeconomic status, and BMI in relation to self-perception of overweight. Obes Res. 2002;10:345-350.